logo

Biohaven Pharmaceutical Holding Co Ltd. (BHVN)



Trade BHVN now with
  Date
  Headline
6/24/2020 7:09:29 AM Biohaven Announces Obsessive-Compulsive Disorder Proof Of Concept Phase 2/3 Study Results And Program Update
6/10/2020 7:01:10 AM Biohaven Adds Bob Hugin To Its Board
5/18/2020 7:38:34 AM Biohaven Showcases Clinical And Pharmacoeconomic Data For NURTEC ODT With 25 Presentations On 2020 AAN
4/27/2020 7:40:16 AM Biohaven Agrees With Genpharm For Distribution Of NURTEC™ ODT In The Middle East
4/16/2020 7:36:00 AM Biohaven Partners With Medison Pharma To Distribute NURTEC™ ODT In Israel
4/9/2020 7:35:29 AM Biohaven Plans To Study Intranasal Vazegepant In Pulmonary Complications Of COVID-19 Disease
4/7/2020 7:35:24 AM Biohaven Announces Collaboration With Cove
3/30/2020 7:42:11 AM Biohaven Achieves Positive Results In Pivotal Trial Of Oral NURTEC
3/23/2020 7:33:49 AM Biohaven To Advance Vazegepant Into Phase 3 Following Successful End Of Phase 2 Meeting With FDA
3/18/2020 7:35:36 AM Biohaven's Verdiperstat Gets Fast Track Designation For Treatment Of Multiple System Atrophy
3/13/2020 7:35:17 AM Biohaven Reports Patient Savings Program; Patients Can Pay $0 For NURTEC ODT For Acute Treatment Of Migraine In Adults
2/14/2020 7:34:42 AM Kleo Pharma Announces Appointment Of CEO Doug Manion To Chairman Of Board